MIAMI, FL / ACCESSWIRE / July 14, 2020 / AllStar Health Brands Inc. (OTC PINK:ALST) a specialty pharmaceutical and nutritional supplements company is pleased to announce an order for Covid-19 Rapid Antibody tests for sales in Florida. The demand for these types of test kits which can deliver results in minutes may help with managing the recent uptick of new infections in Florida and other states as well.
Dr. Daniel Bagi, President of AllStar stated,” The recent uptick in new coronavirus cases in many states, and especially in Florida is a troubling statistic. We are working with local distributors to offer clinics and hospitals more access to these rapid antibody tests. As the acceptance of these types of tests take hold, we expect an increase in the volume and frequency of these orders.
We believe the tests we distribute are among the best available and have been validated by several top-tier reference labs. These types of antibody tests can help determine if an individual has started to produce antibodies to fight the coronavirus infection. Together with the clinical picture, rapid antibody tests are an important part of the arsenal against Covid-19 and can be used as one of the tools shaping future policy strategies.”
About AllStar Health Brands Inc.:
AllStar Health Brands Inc. is a Nevada Corporation established in 2017, and headquartered in Miami, Florida. AllStar is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select products, including medical devices, nutritional supplements, over the counter remedies and medicines all across the Americas and Europe. AllStar’s goal is to bring additional products to the market and provide new, innovative options for better health and wellbeing.
For more information, please contact Investor Relations at (305) 423 7028.
Safe Harbor Statement
Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.
SOURCE: Allstar Health Brands, Inc.
View source version on accesswire.com: